Profil
Jeffrey Skinner is currently Chief Executive Officer at Stoked Bio, Inc. since 2024.
Formerly, Mr. Skinner was Vice President-Business Development at Valeo Pharma, Inc. from 2014 to 2023, Director-Business Development at SteriMax, Inc. from 2012 to 2014, and Vice President-Business Development at ChitogenX, Inc. Education includes an undergraduate degree (1997) and an MBA (1999) from the University of Western Ontario.
Postes actifs de Jeffrey Skinner
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Jeffrey Skinner
| Sociétés | Poste | Fin |
|---|---|---|
| VALEO PHARMA INC. | Corporate Officer/Principal | 01/07/2023 |
SteriMax, Inc.
SteriMax, Inc. Pharmaceuticals: MajorHealth Technology Develops, produces, markets and distributes hospital and retail pharmacy products | Corporate Officer/Principal | 01/07/2014 |
| CHITOGENX INC. | Corporate Officer/Principal | - |
Formation de Jeffrey Skinner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SteriMax, Inc.
SteriMax, Inc. Pharmaceuticals: MajorHealth Technology Develops, produces, markets and distributes hospital and retail pharmacy products | Health Technology |
ChitogenX, Inc.
ChitogenX, Inc. BiotechnologyHealth Technology Operates as a development stage biotechnology company | Health Technology |
Valeo Pharma, Inc.
Valeo Pharma, Inc. Medical DistributorsDistribution Services Wholesales and retails pharmaceuticals & hospital specialty products | Distribution Services |
















